We focus on FDA-approved GLP-1 care pathways.
Why is prior authorization a barrier for obesity medications?
This sits in the insurance coverage step, before a prescription is filled or coverage is finalized.
Prior authorization means your health plan requires information from the prescriber before deciding whether it will cover a medication. Plans may use it to check whether a request meets the plan’s coverage rules. CMS explains how prior authorization and coverage decisions work.
For obesity medications, the process can be a barrier because requirements vary by plan. A plan may require documentation, a specific diagnosis or indication, prior use of another medication, or other criteria before coverage is approved. The exact rules come from your plan’s formulary and benefit documents.
A prior authorization request can also be delayed if information is missing or does not match the plan’s criteria. If the plan denies the request, the denial notice should explain the reason and describe available appeal rights. CMS says denial notices must explain the reason for the decision and the appeal process.
GLP-1 Navigator does not determine whether a medication meets your plan’s requirements. You can ask the prescribing office or your insurer which criteria apply and what documents are needed before submitting or appealing a request.